Form 4: Septerna Inc. Director Shalini Sharp Granted Stock Options

Septerna Inc. director Shalini Sharp has been granted 15,000 stock options with an exercise price of $37.34, vesting under specific service conditions.

Summary

• Shalini Sharp, a Director at Septerna, Inc., was granted 15,000 stock options on June 26, 2026.
• The stock options have an exercise price of $37.34 per share.
• These options are for the company's Common Stock.
• The underlying shares are subject to vesting conditions: full vesting occurs on the earlier of June 26, 2027, or the company's next annual meeting, contingent on Ms. Sharp's continued service.
• A substitute Power of Attorney was filed on February 10, 2026, appointing Gil M. Labrucherie and Mark A. Wilson as substitute attorneys-in-fact for various individuals, including Shalini Sharp, for SEC filings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard stock option grant to a director, which is a routine event and does not inherently signal significant positive or negative developments for the company.

Positives

• Grant of stock options to a director can indicate management's commitment and alignment with shareholder interests.
• The exercise price of $37.34 suggests a valuation at the time of grant, potentially reflecting market conditions or company performance.

Risks

• The vesting schedule is contingent on continued service, meaning the options may not fully vest if the reporting person leaves the company before the specified dates.
• The value of the stock options is subject to market fluctuations and the future performance of Septerna, Inc.

Future Outlook

The stock options granted to Shalini Sharp are exercisable up to June 25, 2036, with full vesting expected by June 26, 2027, or the next annual meeting, provided she remains in service.

Industry Context

StockSavvy.ai notes that the grant of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, like Septerna, Inc., to incentivize long-term performance and align executive interests with those of shareholders.

Corporate Governance

Stakeholder Impact

• Shareholders: The stock option grant aligns director incentives with shareholder value creation, potentially leading to improved long-term performance.
• Employees: While not directly impacted, the alignment of director incentives can contribute to overall company stability and growth, indirectly benefiting employees.
• Management: The grant reinforces the importance of continued service and performance for executive compensation.

Next Steps

• Shalini Sharp will continue her service to Septerna, Inc. through the vesting dates to fully acquire the granted stock options.
• The company will continue to operate under the terms of the Power of Attorney filed on February 10, 2026, for SEC filings.

Key Dates

Keywords

Form 4, Stock Options, Septerna Inc., SEPN, Director, Beneficial Ownership, SEC Filing, Securities Exchange Act, Power of Attorney